Tian Zhang: Looking forward to Alliance for Clinical Trials in Oncology fall meeting
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, shared a post by Stephanie Berg, Instructor of Medicine at Harvard Medical School, on X:
“Looking forward to Alliance for Clinical Trials in Oncology fall meeting! En route to Chicago! See you soon, Stephanie Berg, Alan Tan, Rana McKay, Dan George, Jonathan Rosenberg, Matt Galsky, Andrea Apolo and many friends.”
Quoting Stephanie Berg’s post:
“Excited to connect with colleagues at Alliance for Clinical Trials in Oncology fall group meeting! If you are a member and haven’t registered yet, attend! It’s a packed 3 day event!”
Tian Zhang is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies. She has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers. She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma. She serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee.
She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention & Research Institute of Texas (CPRIT) Scholar Rising Stars Award.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023